Fobi AI Inc. announced that the company's wholly-owned subsidiary, PulseIR, has signed a new deal with integrated healthcare provider, Empower Clinics. Empower offers a telemedicine platform for healthcare and diagnostics solutions across the U.S. and Canada. PulseIR is a platform as a service (PaaS) and Fobi will generate $120,000 in revenue for the one-year contract.

This revenue will be recognized in accordance with IFRS policies over the 12 months of the contract. PulseIR recently made its public commercial launch on January 30, 2023, with its first client PanGenomic Health Inc. This second contract with Empower Clinics validates the interest and demand for public issuers that are looking to deliver personalized, automated, and data-driven mobile IR solutions to their shareholders.